BCAB
BioAtla
Stock NASDAQ – Stock Market Prices, News & Analysis
BioAtla Inc développe des anticorps conditionnelement actifs pour traiter les maladies graves, principalement le cancer, en utilisant leur plateforme technologique CAB (Conditionally Active Biologics).
$ 4.61
18.35 %
BioAtla
$
4.61
18.35 %
BCAB
BioAtla Inc développe des anticorps conditionnelement actifs pour traiter les maladies graves, principalement le cancer, en utilisant leur plateforme technologique CAB (Conditionally Active Biologics).
Price history of BioAtla
Price history of BioAtla
Performance & Momentum
6 Months
81.27 %
1 Year
56.67 %
3 Years
95.41 %
5 Years
99.72 %
Similar stocks to BioAtla
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
